{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2024,2,10]],"date-time":"2024-02-10T00:14:34Z","timestamp":1707524074870},"reference-count":18,"publisher":"Springer Science and Business Media LLC","content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":[],"published-print":{"date-parts":[[2020,6,22]]},"DOI":"10.7759\/cureus.8777","type":"journal-article","created":{"date-parts":[[2020,6,23]],"date-time":"2020-06-23T04:55:12Z","timestamp":1592888112000},"source":"Crossref","is-referenced-by-count":0,"title":["Late Pathomorphological Features of the Endocrine Pancreas in Patients With Type 2 Diabetes Mellitus"],"prefix":"10.7759","author":[{"given":"Irina","family":"Tomova","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"George S","family":"Stoyanov","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Deyan L","family":"Dzhenkov","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Lilyana","family":"Petkova","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"297","reference":[{"key":"ref1","doi-asserted-by":"publisher","DOI":"10.1007\/bf00404025","article-title":"Basal and stimulated plasma levels of pancreatic amylin indicate its co-secretion with insulin in humans","volume":"34","author":"Hartter E","year":"1991","unstructured":"Hartter E, Svoboda T, Ludvik B, et al.. Basal and stimulated plasma levels of pancreatic amylin indicate its co-secretion with insulin in humans. Diabetologia. 1991, 34:52-54. 10.1007\/bf00404025","journal-title":"Diabetologia"},{"key":"ref2","doi-asserted-by":"crossref","DOI":"10.1016\/S0021-9258(19)77825-9","article-title":"An islet amyloid peptide is derived from an 89-amino acid precursor by proteolytic processing","volume":"263","author":"Sanke T","year":"1988","unstructured":"Sanke T, Bell GI, Sample C, Rubenstein AH, Steiner DF. An islet amyloid peptide is derived from an 89-amino acid precursor by proteolytic processing. J Biol Chem. 1988, 263:17243-17246.","journal-title":"J Biol Chem"},{"key":"ref3","doi-asserted-by":"publisher","DOI":"10.1007\/s001250050646","article-title":"Infusion of pramlintide, a human amylin analogue, delays gastric emptying in men with IDDM","volume":"40","author":"Kong MF","year":"1997","unstructured":"Kong MF, King P, Macdonald IA, et al.. Infusion of pramlintide, a human amylin analogue, delays gastric emptying in men with IDDM. Diabetologia. 1997, 40:82-88. 10.1007\/s001250050646","journal-title":"Diabetologia"},{"key":"ref4","doi-asserted-by":"publisher","DOI":"10.1016\/S0167-0115(02)00252-5","article-title":"Islet amyloid polypeptide inhibits glucagon release and exerts a dual action on insulin release from isolated islets","volume":"111","author":"\u00c5kesson B","year":"2003","unstructured":"\u00c5kesson B, Panagiotidis G, Westermark P, Lundquist I. Islet amyloid polypeptide inhibits glucagon release and exerts a dual action on insulin release from isolated islets. Reg Pept. 2003, 111:55-60. 10.1016\/S0167-0115(02)00252-5","journal-title":"Reg Pept"},{"key":"ref5","doi-asserted-by":"publisher","DOI":"10.1016\/0306-4522(94)90388-3","article-title":"In vitro autoradiographic localization of amylin binding sites in rat brain","volume":"62","author":"Sexton PM","year":"1994","unstructured":"Sexton PM, Paxinos G, Kenney MA, Wookey PJ, Beaumont K. In vitro autoradiographic localization of amylin binding sites in rat brain. Neurosci. 1994, 62:553-567. 10.1016\/0306-4522(94)90388-3","journal-title":"Neurosci"},{"key":"ref6","doi-asserted-by":"publisher","DOI":"10.3109\/03009734.2011.573884","article-title":"Amyloid in the islets of Langerhans: thoughts and some historical aspects","volume":"116","author":"Westermark P","year":"2011","unstructured":"Westermark P. Amyloid in the islets of Langerhans: thoughts and some historical aspects. Ups J Med Sci. 2011, 116:81-89. 10.3109\/03009734.2011.573884","journal-title":"Ups J Med Sci"},{"key":"ref7","doi-asserted-by":"publisher","DOI":"10.1016\/0014-5793(95)01512-4","article-title":"Effects of beta cell granule components on human islet amyloid polypeptide fibril formation","volume":"379","author":"Westermark P","year":"1996","unstructured":"Westermark P, Li ZC, Westermark GT, Leckstr\u00f6m A, Steiner DF. Effects of beta cell granule components on human islet amyloid polypeptide fibril formation. FEBS Lett. 1996, 379:203-206. 10.1016\/0014-5793(95)01512-4","journal-title":"FEBS Lett"},{"key":"ref8","doi-asserted-by":"publisher","DOI":"10.1210\/jc.2004-0405","article-title":"Islet amyloid: a critical entity in the pathogenesis of type 2 diabetes","volume":"89","author":"Hull RL","year":"2004","unstructured":"Hull RL, Westermark GT, Westermark P, Kahn SE. Islet amyloid: a critical entity in the pathogenesis of type 2 diabetes. JCEM. 2004, 89:3629-3643. 10.1210\/jc.2004-0405","journal-title":"JCEM"},{"key":"ref9","doi-asserted-by":"publisher","DOI":"10.1007\/s00125-003-1304-4","article-title":"Islet amyloid: a complication of islet dysfunction or an aetiological factor in type 2 diabetes?","volume":"47","author":"Clark A","year":"2004","unstructured":"Clark A, Nilsson MR. Islet amyloid: a complication of islet dysfunction or an aetiological factor in type 2 diabetes?. Diabetologia. 2004, 47:157-169. 10.1007\/s00125-003-1304-4","journal-title":"Diabetologia"},{"key":"ref10","doi-asserted-by":"publisher","DOI":"10.1021\/bi00044a038","article-title":"Effect of pH and insulin on fibrillogenesis of islet amyloid polypeptide in vitro","volume":"34","author":"Charge SB","year":"1995","unstructured":"Charge SB, de Koning EJ, Clark A. Effect of pH and insulin on fibrillogenesis of islet amyloid polypeptide in vitro. Biochem. 1995, 34:14588-14593. 10.1021\/bi00044a038","journal-title":"Biochem"},{"key":"ref11","doi-asserted-by":"publisher","DOI":"10.4239\/wjd.v7.i9.189","article-title":"Neuroendocrine hormone amylin in diabetes","volume":"7","author":"Zhang XX","year":"2016","unstructured":"Zhang XX, Pan YH, Huang YM, Zhao HL. Neuroendocrine hormone amylin in diabetes. World J Diabetes. 2016, 7:189-197. 10.4239\/wjd.v7.i9.189","journal-title":"World J Diabetes"},{"key":"ref12","doi-asserted-by":"publisher","DOI":"10.1126\/science.1079469","article-title":"Common structure of soluble amyloid oligomers implies common mechanism of pathogenesis","volume":"300","author":"Kayed R","year":"2003","unstructured":"Kayed R, Head E, Thompson JL, et al.. Common structure of soluble amyloid oligomers implies common mechanism of pathogenesis. Sci. 2003, 300:486-489. 10.1126\/science.1079469","journal-title":"Sci"},{"key":"ref13","doi-asserted-by":"publisher","DOI":"10.1021\/bi034889i","article-title":"The human islet amyloid polypeptide forms transient membrane-active prefibrillar assemblies","volume":"42","author":"Porat Y","year":"2003","unstructured":"Porat Y, Kolusheva S, Jelinek R, Gazit E. The human islet amyloid polypeptide forms transient membrane-active prefibrillar assemblies. Biochemistry. 2003, 42:10971-10977. 10.1021\/bi034889i","journal-title":"Biochemistry"},{"key":"ref14","doi-asserted-by":"publisher","DOI":"10.2337\/diabetes.48.3.491","article-title":"The mechanism of islet amyloid polypeptide toxicity is membrane disruption by intermediate-sized toxic amyloid particles","volume":"48","author":"Janson J","year":"1999","unstructured":"Janson J, Ashley RH, Harrison D, McIntyre S, Butler PC. The mechanism of islet amyloid polypeptide toxicity is membrane disruption by intermediate-sized toxic amyloid particles. Diabetes. 1999, 48:491-498. 10.2337\/diabetes.48.3.491","journal-title":"Diabetes"},{"key":"ref15","doi-asserted-by":"publisher","DOI":"10.1038\/368756a0","article-title":"Pancreatic islet cell toxicity of amylin associated with type-2 diabetes mellitus","volume":"368","author":"Lorenzo A","year":"1994","unstructured":"Lorenzo A, Razzaboni B, Weir GC, Yankner BA. Pancreatic islet cell toxicity of amylin associated with type-2 diabetes mellitus. Nature. 1994, 368:756-760. 10.1038\/368756a0","journal-title":"Nature"},{"key":"ref16","doi-asserted-by":"publisher","DOI":"10.1084\/jem.5.5.527","article-title":"The relation of diabetes mellitus to lesions of the pancreas: hyaline degeneration of the islets of Langerhans","volume":"5","author":"Opie EL","year":"1901","unstructured":"Opie EL. The relation of diabetes mellitus to lesions of the pancreas: hyaline degeneration of the islets of Langerhans. J Exp Med. 1901, 5:527-540. 10.1084\/jem.5.5.527","journal-title":"J Exp Med"},{"key":"ref17","doi-asserted-by":"publisher","DOI":"10.1073\/pnas.84.23.8628","article-title":"Purification and characterization of a peptide from amyloid-rich pancreases of type 2 diabetic patients","volume":"84","author":"Cooper GJS","year":"1987","unstructured":"Cooper GJS, Willis AC, Clark A, Turner RC, Sim RB, Reid KB. Purification and characterization of a peptide from amyloid-rich pancreases of type 2 diabetic patients. Proc Natl Acad Sci USA. 1987, 84:8628-8632. 10.1073\/pnas.84.23.8628","journal-title":"Proc Natl Acad Sci USA"},{"key":"ref18","doi-asserted-by":"publisher","DOI":"10.1073\/pnas.84.11.3881","article-title":"Amyloid fibrils in human insulinoma and islets of Langerhans of the diabetic cat are derived from a neuropeptide-like protein also present in normal islet cells","volume":"84","author":"Westermark P","year":"1987","unstructured":"Westermark P, Wernstedt C, Wilander E, Hayden DW, O\u2019Brien TD, Johnson KH. Amyloid fibrils in human insulinoma and islets of Langerhans of the diabetic cat are derived from a neuropeptide-like protein also present in normal islet cells. Proc Natl Acad Sci USA. 1987, 84:3881-3885. 10.1073\/pnas.84.11.3881","journal-title":"Proc Natl Acad Sci USA"}],"container-title":["Cureus"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/www.cureus.com\/articles\/34863-late-pathomorphological-features-of-the-endocrine-pancreas-in-patients-with-type-2-diabetes-mellitus","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2024,2,9]],"date-time":"2024-02-09T19:26:39Z","timestamp":1707506799000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.cureus.com\/articles\/34863-late-pathomorphological-features-of-the-endocrine-pancreas-in-patients-with-type-2-diabetes-mellitus"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2020,6,22]]},"references-count":18,"URL":"https:\/\/doi.org\/10.7759\/cureus.8777","relation":{},"ISSN":["2168-8184"],"issn-type":[{"value":"2168-8184","type":"print"}],"subject":[],"published":{"date-parts":[[2020,6,22]]}}}